Goldseeker you said
"No Australian patents. They are all expired or lapsed."
Wolfie says
True there are no Australian Patents..But you are wrong about "All" have expired or lapsed. Here is the one you missed..
2011901578 Methods for detecting and monitoring cancer AMDL Australia Pty. Ltd. Dirks, Chistopher; Charter, Dennis; Brown, Darren 2011-04-29 LAPSED
Thanks to your current listing of patents in Australia, It has not lapsed or expired..DCMAN check out the date Mac filed the patent in Australia and New Zealand..It is September 14, 2011..Check out the dates on the post below by Goldseeker..The last date for the patents expired or lapsed in Australia accoreding to Goldseeker's recent reasearch on Australian patents was on April 24, 2011.
Clearly this Proves that Radient has a Patent Pending in Australia...Wolfie
2011901578 Methods for detecting and monitoring cancer AMDL Australia Pty. Ltd. Dirks, Chistopher; Charter, Dennis; Brown, Darren 2011-04-29 LAPSED
Radient Pharmaceuticals Files International Patents in Australia and New Zealand
Radient Pharmaceuticals Corporation September 14, 2011 7:00 AM
TUSTIN, CA--(Marketwire -09/14/11)- Radient Pharmaceuticals Corporation "the Company" or "Radient" (OTCQX: RXPC.PK - News) (Pinksheets: RXPC.PK - News), a developer and marketer of In Vitro Diagnostic (IVD) cancer tests, today announced it has filed for patent protection for its proprietary Onko-Sure® cancer test in Australia and New Zealand.
"Building an intellectual property position in foreign markets protects and supports sales of our proprietary Onko-Sure® cancer test globally. Both Australia and New Zealand have highly developed healthcare markets where we believe Onko-Sure® can add value as a minimally invasive, relatively low cost cancer diagnostic," stated Radient Chairman and CEO Douglas MacLellan.
The Onko-Sure® test kit is a 96-well ELISA test kit sold to clinical reference labs. Labs run individual tests prescribed by doctors. Blood samples can be run, in duplicate, for 40 people, on each test kit. Onko-Sure® is a non-invasive cancer blood test that has been shown, in a large body of published clinical research, to be effective in the detection of 19 different cancers.
Gold Seeker Friday, 09/19/14 04:46:15 PM
Re: guardiangel post# 25321
Post # of 25363
No Australian patents. They are all expired or lapsed.
2011901578 Methods for detecting and monitoring cancer AMDL Australia Pty. Ltd. Dirks, Chistopher; Charter, Dennis; Brown, Darren 2011-04-29 LAPSED
2 2009343805 Detection of fibrin and fibrinogen degradation products and associated methods of production and use for the detection and monitoring of cancer AMDL, Inc. Small-Howard, Andrea 2009-03-30 LAPSED
3 1998077134 Immunoassay for the detection of cancer AMDL, Inc. Cress, Michael C.; Moore, Ronald J.; Ngo, That T. 1998-06-02 LAPSED
4 1995037285 Antibodies against an extracellular matrix complex and their use in the detection of cancer AMDL, Inc. Lallone, Roger L 1995-09-27 LAPSED
5 1990060934 An in vitro method and probe for detecting the presence of the ring shaped particle and malignancy in humans and animals AMDL, Inc. Guerrero, Robert R. 1990-08-13 CEASED
AU-A: UNITED STATES OF AMERICA (43) Publication Date: 23.01.92 (71) Applicant(s) AMDL, INC. (72) Inventor(s) ROBERT R. GUERRERO (74) Attorney or Agent
